These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2039185)

  • 1. [The value of nuclear magnetic resonance in the study of iron overload in thalassemia patients].
    Perrimond H; Chagnon C; Moulanier I; Michel G; Guidicelli H; Bernard PJ
    Ann Pediatr (Paris); 1991 Mar; 38(3):175-84. PubMed ID: 2039185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*.
    Kolnagou A; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2006; 30(2):219-27. PubMed ID: 16798647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocyte damage and loss of myofibers is the potential mechanism of iron overload toxicity in congestive cardiac failure in thalassemia. Complete reversal of the cardiomyopathy and normalization of iron load by deferiprone.
    Kolnagou A; Michaelides Y; Kontos C; Kyriacou K; Kontoghiorghes GJ
    Hemoglobin; 2008; 32(1-2):17-28. PubMed ID: 18274979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients.
    Hashemieh M; Azarkeivan A; Akhlaghpoor S; Shirkavand A; Sheibani K
    Arch Iran Med; 2012 Feb; 15(2):91-4. PubMed ID: 22292579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
    Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
    Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessmrent of iron overload in thalassaemic patients by magnetic resonance imaging: a pilot study.
    Kumar P; Jagannathan NR; Choudhry VP
    J Indian Med Assoc; 2007 Oct; 105(10):561-4, 591. PubMed ID: 18383951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study.
    Casale M; Meloni A; Filosa A; Cuccia L; Caruso V; Palazzi G; Gamberini MR; Pitrolo L; Putti MC; D'Ascola DG; Casini T; Quarta A; Maggio A; Neri MG; Positano V; Salvatori C; Toia P; Valeri G; Midiri M; Pepe A
    Circ Cardiovasc Imaging; 2015 Aug; 8(8):e003230. PubMed ID: 26253625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemosiderosis in thalassemia major. Quantitative study with magnetic resonance (MR)].
    Rossi L; Castriota-Scanderbeg A; Ferrozzi F; Butturini A; Rossi A
    Radiol Med; 1992 Mar; 83(3):237-42. PubMed ID: 1579672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance.
    Anderson LJ; Westwood MA; Holden S; Davis B; Prescott E; Wonke B; Porter JB; Walker JM; Pennell DJ
    Br J Haematol; 2004 Nov; 127(3):348-55. PubMed ID: 15491298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The uses and differences of r2 and r2* in the determination of iron overload in iron loaded thalassemia patients.
    Gotsis ED
    Hemoglobin; 2008; 32(1-2):75-83. PubMed ID: 18274985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2* magnetic resonance and myocardial iron in thalassemia.
    Pennell DJ
    Ann N Y Acad Sci; 2005; 1054():373-8. PubMed ID: 16339685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
    Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a web-based network for reproducible T2* MRI assessment of iron overload in thalassemia.
    Meloni A; Ramazzotti A; Positano V; Salvatori C; Mangione M; Marcheschi P; Favilli B; De Marchi D; Prato S; Pepe A; Sallustio G; Centra M; Santarelli MF; Lombardi M; Landini L
    Int J Med Inform; 2009 Aug; 78(8):503-12. PubMed ID: 19345609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload.
    Pepe A; Positano V; Santarelli MF; Sorrentino F; Cracolici E; De Marchi D; Maggio A; Midiri M; Landini L; Lombardi M
    J Magn Reson Imaging; 2006 May; 23(5):662-8. PubMed ID: 16568436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and therapy of iron overload with desferrioxamine].
    Andres J; Stobbe H
    Z Gesamte Inn Med; 1984 Apr; 39(8):167-9. PubMed ID: 6730593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ; Göbel U; Christaras A; Janssen G
    Klin Padiatr; 2005; 217(3):120-5. PubMed ID: 15858702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
    Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
    Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron metabolism in thalassemia intermedia.
    Fiorelli G; Fargion S; Piperno A; Battafarano N; Cappellini MD
    Haematologica; 1990; 75 Suppl 5():89-95. PubMed ID: 2086386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.